ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 236 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $423,594 | -4.2% | 32,237 | -8.1% | 0.00% | – |
| Q2 2023 | $442,197 | -18.7% | 35,095 | -15.8% | 0.00% | -100.0% |
| Q1 2023 | $543,754 | -65.1% | 41,667 | -52.8% | 0.00% | -50.0% |
| Q4 2022 | $1,555,954 | +36.6% | 88,206 | +17.9% | 0.00% | +100.0% |
| Q3 2022 | $1,139,000 | +5.8% | 74,809 | +3.0% | 0.00% | 0.0% |
| Q2 2022 | $1,077,000 | -36.1% | 72,605 | -11.0% | 0.00% | -50.0% |
| Q1 2022 | $1,686,000 | +63.2% | 81,623 | +45.8% | 0.00% | +100.0% |
| Q4 2021 | $1,033,000 | +36.5% | 55,973 | -1.1% | 0.00% | 0.0% |
| Q3 2021 | $757,000 | -31.2% | 56,609 | -4.8% | 0.00% | 0.0% |
| Q2 2021 | $1,101,000 | +10.2% | 59,455 | -10.6% | 0.00% | 0.0% |
| Q1 2021 | $999,000 | +48.9% | 66,519 | +43.1% | 0.00% | 0.0% |
| Q4 2020 | $671,000 | +309.1% | 46,494 | +130.1% | 0.00% | – |
| Q3 2020 | $164,000 | +9.3% | 20,208 | -8.7% | 0.00% | – |
| Q2 2020 | $150,000 | -79.6% | 22,138 | -78.8% | 0.00% | -100.0% |
| Q1 2020 | $736,000 | +49.9% | 104,548 | +109.0% | 0.00% | 0.0% |
| Q4 2019 | $491,000 | +79.9% | 50,023 | +101.1% | 0.00% | – |
| Q3 2019 | $273,000 | -96.8% | 24,875 | -97.2% | 0.00% | -100.0% |
| Q4 2018 | $8,427,000 | -32.4% | 874,213 | -0.1% | 0.02% | -19.2% |
| Q3 2018 | $12,467,000 | -35.2% | 874,863 | -45.4% | 0.03% | -36.6% |
| Q2 2018 | $19,243,000 | +11.4% | 1,603,613 | +14.7% | 0.04% | +7.9% |
| Q1 2018 | $17,268,000 | -25.2% | 1,398,253 | -11.9% | 0.04% | -22.4% |
| Q4 2017 | $23,080,000 | -17.3% | 1,586,243 | -19.1% | 0.05% | -22.2% |
| Q3 2017 | $27,906,000 | +34.4% | 1,961,033 | +20.5% | 0.06% | +28.6% |
| Q2 2017 | $20,763,000 | +7.5% | 1,627,164 | +6.8% | 0.05% | +6.5% |
| Q1 2017 | $19,321,000 | -14.1% | 1,523,769 | -30.9% | 0.05% | -19.3% |
| Q4 2016 | $22,500,000 | -37.2% | 2,203,739 | -19.0% | 0.06% | -43.0% |
| Q3 2016 | $35,840,000 | – | 2,721,313 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |